AMY WALKER: Open Payments
NPI 1215026695 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,949 in 147 payments from 16 companies in 2025. Trend: 2023 $588 · 2024 $2,837 · 2025 $2,949
Food & beverage: $2,949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $684 |
| Amgen Inc. | 28 | $494 |
| UCB, Inc. | 18 | $433 |
| AstraZeneca Pharmaceuticals LP | 14 | $315 |
| GENZYME CORPORATION | 5 | $271 |
| E.R. Squibb & Sons, L.L.C. | 12 | $197 |
| Novartis Pharmaceuticals Corporation | 8 | $144 |
| Radius Health, Inc. | 6 | $123 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Fresenius Kabi USA, LLC | 3 | $49 |
Products named: RINVOQ, Bimzelx, SAPHNELO, EVENITY, ORENCIA, COSENTYX, KEVZARA, Tymlos.
Industry payments across OK — which companies pay providers there.
